Growth · alternatives · 2026
24 alternatives to Molecular Diagnostics Market 2021
Global Molecular Diagnostics Market- Industry Trends
Below are 24 products that do a similar job, ranked by how close each is in meaning and then by launch-day votes. Molecular Diagnostics Market 2021 launched in 2021; newer entries below may have overtaken it.
- 1
Molecule Data▲121Simplify data: manage ads, budgets & compare performance
2024 · moleculedata.com · its alternatives →
- 2
Liquid Biopsy Market (2026 - 2033)
Aug 2026 · grandviewresearch.com · its alternatives →
- 3
35+ reports (CB Insights, McKinsey, Wired, etc.)
2021 · spacecadet.ventures · its alternatives →
- 4
Market Test▲177Validate human and AI-generated creative assets in 2 hours
2023 · conjointly.com · its alternatives →
- 5
Big Data analytics solutions
2016 · clavax.com · its alternatives →
- 6
- 7
The "CoinMarketCap" for companies
2021 · companiesmarketcap.com · its alternatives →
- 8
Latest trends on database tech, tools, and industry data.
2022 · stateofdb.com · its alternatives →
- 9
DNA test to measure genetic compatibility btw couples
2014 · instantchemistry.com · its alternatives →
- 10
Report featuring 141 companies and $1.6 Billion of funding
2020 · its alternatives →
- 11
Check profitability of your email marketing campaigns
2021 · didoagency.com · its alternatives →
- 12
Molecule is a Go library for parsing protobufs in an efficient and zero-allocation manner. - GitHub - richardartoul/molecule: Molecule is a Go library for parsing protobufs in an efficient and zero-allocation manner.
2020 · github.com · its alternatives →
- 13
- 14
Amblyopia Market –Global Industry Analysis
2021 · growthmarketreports.com · its alternatives →
- 15
Reducing costs to speed up innovation
2016 · soundcloud.com · its alternatives →
- 16
Hi HN, My friend and I have been experimenting with using LLMs to reason about biotech stocks. Unlike many other sectors, Biotech trading is largely event-driven: FDA decisions, clinical trial readouts, safety updates, or changes in trial design can cause a stock to 3x in a single day (https://www.biotradingarena.com/cases/MDGL_2023-12-14_Resmet...). Interpreting these ‘catalysts,’ which comes in the form of a press release, usually requires analysts with previous expertise in biology or medicine. A catalyst that sounds “positive” can still lead to a selloff if, for…
Feb 2026 · biotradingarena.com · its alternatives →
- 17
Jared Fuller on how he skyrocketed PandaDoc
2016 · traffic.libsyn.com · its alternatives →
- 18
Automotive Vehicle To-everything market size | forecast 2031
2025 · kbvresearch.com · its alternatives →
- 19SH
I analyzed 10 years of Hacker News data (2016-2025) to track Show HN submission trends. - Show HN posts went from ~900/month (2016-2019) to 3,315 in Dec 2025 - Share of all stories: 2.4% (2016) → 12.8% (Dec 2025) - Notable spikes: COVID-19 (2020), AI boom (2023), and accelerating growth through 2024-2025 Data source: HackerBook (144k Show HN posts / 3.4M total stories)
Jan 2026 · imgur.com · its alternatives →
- 20
- 21
Examination Lights Market to Reach $259.6 Million by 2026
2020 · fortunebusinessinsights.com · its alternatives →
- 22
Input a SMILES string (or pick one molecule from the examples) and it returns up to 100k molecules closest in 3-D shape or electrostatic similarity – from 10+ billion scale databases — typically in under 5-10 s. *Why it might interest HN* * Entire index lives on disk — no GPU at query-time, less than ~10 GB RAM total. * Built from scratch (no FAISS index / Milvus / Pinecone). * Index-build cost: one Nvidia T4 (~ 300USD) for one 5.5B database. * Open to anyone, predict ADMET, export results as CSV/SDF. Full write-up & benchmarks (DUD-E, LIT-PCBA, SVS) in the pre-print:…
2025 · cheese-new.deepmedchem.com · its alternatives →
- 23
U.S Technology Market Size, Share,Trends Analysis Report
2025 · databridgemarketresearch.com · its alternatives →
- 24
Also compare
Ranked by how close each launch is in meaning, then by votes. Prices were read from each product’s own site when checked and can change. Refine with your own description →